Our pricing and market access services include:
- RPR stakeholder engagement platform
- HTA landscape
- Disease landscapes
- Pricing and reimbursement landscape
- Contracting/formulary decisions landscape
- Briefing or strategic playbooks
- Target product profile optimization
- Value message development
- Objection handlers
- Product Value Proposition (PVP) development
- Stakeholder mapping
- Payer segmentation
- Therapy benchmarking/minimum required magnitude of benefit
- Advisory boards
- Strategy workshops
- Market access concept workshop with payers
Secure robust insights with our unique stakeholder engagement platform
Direct stakeholder engagement is critical when assessing your access and pricing strategy, insights, and messaging. Supported by our experts, our online RPR platform leverages a global network of 3,000+ vetted stakeholders across 65+ countries to secure robust insights in a fraction of the time and cost of a traditional approach.
The RPR platform integrates real-world insights from decision-makers, enriching research findings and bridging data gaps to align with research goals.
RPR not only fills research gaps but also refines insight. For instance, while secondary research might hint at a need for more RWE, RPR pinpoints the methodologies and outcomes acceptable to payers.
RPR dives deeper than traditional research, sourcing data directly from key audiences, including payers, physicians, KOLs, and patient advocacy groups.
Manufacturers can fine-tune their market access and pricing strategies with RPR, enabling precise decision-making and clear identification of both risks and opportunities.
Accelerated Insight Generation
Where technology meets market access expertise
Supported by specialist teams, our suite of agile technology platforms allows us to provide clients with enhanced pricing and market access services by delivering impactful insights at an accelerated rate.
Our RPR platform can be employed to integrate stakeholder insights into any aspect of product development and commercialization. EVID AI enhances and accelerates literature reviews; RWE Dashboards leverage data visualization techniques to transform and extrapolate value from complex data into communicable insights; and our Integrated Evidence Planning platforms meet the challenge of evidence organization and communication.
Selected access and pricing publications
Our teams have co-authored over 1000 publications across the full range of therapeutic areas, data sources, indications, and methods. A selection of our recent access and pricing related publications can be found below. For a wider list, please visit our publications directory.
|Title||GR Author(s)||Year||Therapeutic Area||Data Source||Journal/Conference||Full Citation & Links|
|Assessment of the relevance and credibility of indirect treatment comparisons to help inform health technology assessment and reimbursement decision-making: results of a 5-country payer survey.||Katsoulis I, Graham A||2023||General Medicine||RPR Survey||ISPOR Europe||View|
|Paradigm Shift or Incremental Change? Real-World Evidence for Health Technology Assessment in Oncology.||Ignjatovic T||2023||Oncology||RPR Survey||ISPOR Europe||View|